CARCINOMA HEPATOCELULAR HISTOLOGIA PDF

Mezim Carcinoma Hepatocelular- Dos fatores de risco ao tratamento. Nevoid basal cell carcinoma syndrome. Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients. Careful examination as well as routine biopsy are crucial for accurate diagnosis. Microscopically, small cell carcinoma was detected as the major tumor component.

Author:Dashicage Tugor
Country:Angola
Language:English (Spanish)
Genre:Business
Published (Last):21 February 2017
Pages:59
PDF File Size:5.49 Mb
ePub File Size:10.97 Mb
ISBN:663-4-96415-623-1
Downloads:44893
Price:Free* [*Free Regsitration Required]
Uploader:Meztikazahn



Please feel free to contact the Webmaster regarding any questions or comments on this page. Discuss the morphologic features of histologic variants of HCC and combined hepatocellular-cholangiocarcinoma with a focus on advantages and pitfalls of various immunohistochemical markers in recognizing the subtypes.

The importance of novel markers including molecular alterations in improving the diagnosis will be discussed. Originally presented on February 5, in Park City, Utah. After completing medical school training in India, he attended the University of Illinois in Chicago for pathology residency followed by GI-liver and molecular pathology fellowships at Mayo Clinic, Rochester, MN.

His principal research interests are focused on hepatocellular adenoma, hepatocellular carcinoma and colorectal cancer. Once the quiz has been passed, you can choose your desired credit type, and enter the information necessary for the credit to be valid and produce a completion certificate. After submitting the user information form, a certificate will be generated based on the credit type you have chosen.

Following the prompts will allow you to download the certificate which you should keep for your records. Additionally, the information that you entered into the form will be saved in our submission database to verify with the accrediting body that you have completed the continuing education activity.

Your information is only used for proof of completion and to notify you of additional educational opportunities. Please feel free to contact the Webmaster regarding any additional questions or comments.

HEINZ TEUCHERT PDF

Hepatocellular Carcinoma: Histologic Subtypes.

Please feel free to contact the Webmaster regarding any questions or comments on this page. Discuss the morphologic features of histologic variants of HCC and combined hepatocellular-cholangiocarcinoma with a focus on advantages and pitfalls of various immunohistochemical markers in recognizing the subtypes. The importance of novel markers including molecular alterations in improving the diagnosis will be discussed. Originally presented on February 5, in Park City, Utah. After completing medical school training in India, he attended the University of Illinois in Chicago for pathology residency followed by GI-liver and molecular pathology fellowships at Mayo Clinic, Rochester, MN. His principal research interests are focused on hepatocellular adenoma, hepatocellular carcinoma and colorectal cancer.

HYPERION DISCLOSURE MANAGEMENT XBRL FILETYPE PDF

Carcinoma hepatocelular (CHC)

In regions where hepatitis B infection is endemic, such as southeast China, this is the predominant cause. Certain benign liver tumors, such as hepatocellular adenoma , may sometimes be associated with coexisting malignant HCC. Evidence is limited for the true incidence of malignancy associated with benign adenomas; however, the size of hepatic adenoma is considered to correspond to risk of malignancy and so larger tumors may be surgically removed. Children and adolescents are unlikely to have chronic liver disease, but if they suffer from congenital liver disorders, this fact increases the chance of developing HCC. Young adults afflicted by the rare fibrolamellar variant of hepatocellular carcinoma may have none of the typical risk factors, i. Diabetes mellitus[ edit ] The risk of hepatocellular carcinoma in type 2 diabetics is greater from 2. A suspected contributor to this increased risk is circulating insulin concentration such that diabetics with poor insulin control or on treatments that elevate their insulin output both states that contribute to a higher circulating insulin concentration show far greater risk of hepatocellular carcinoma than diabetics on treatments that reduce circulating insulin concentration.

ENCICLOPEDIA DE FISICULTURISMO E MUSCULACAO PDF

Hepatocellular carcinoma

.

Related Articles